Riskpilot← Back to searchSign inGet full accessNeli Medicin AB
ABActiveOrg 5593207797Morby 408General medical practice activities · NACE 8621Est. 20212 employees
Revenue 2024
SEK 511K
-9% vs 2023
EBITDA margin
16.8%
+258% vs 2023
Equity ratio
110.6%
Financial strength
Net profit 2024
SEK 66K
+267% vs 2023
| Revenue | SEK 511K | -9% |
| EBITDA | SEK 86K | +258% |
| Net profit | SEK 66K | +267% |
| Total assets | SEK 85K | -49% |
| Equity | SEK 94K | +104% |
| Employees | 2 | — |
Legal name
Neli Medicin AB
Org number
5593207797
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
3 juni 2021
Share capital
SEK 25 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva verksamhet inom medicinsk vård och konsultation såväl som kosmetisk och estetisk behandling samt därtill förenlig verksamhet. Den medicinska vården bedrivs till exempel genom konsulttjänster inom öppen- såväl som slutenvård men även inom vaccinationsmottagningar och digitala vårdrelaterade tjänster. Bolaget ska bedriva behandlingar samt affärsutveckling inom hälsa, kosmetik och estetik. Bolaget kommer att att äga och driva egna mottagningar och kliniker. Bolaget ska äga och förvalta värdepapper. Bolaget ska äga och förvalta fastigheter.
Address
Morby 408
Email
gabriel.dasouki@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 131 | 483 | 560 | 511 |
| Staff expenses | — | — | — | — |
| EBITDA | 94 | 170 | 24 | 86 |
| Depreciation & amort. | −0 | −0 | −0 | −0 |
| EBIT | 94 | 170 | 24 | 86 |
| Net financials | — | −11 | −1 | −1 |
| Profit before tax | 93 | 159 | 23 | 84 |
| Tax | −19 | −35 | −5 | −18 |
| Net profit | 74 | 124 | 18 | 66 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 149 | 382 | 166 | 85 |
| Equity | 99 | 223 | 46 | 94 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 50 | 159 | 120 | 9 |
| Total debt | 50 | 159 | 120 | 9 |
EBITDA margin
16.8%
This company
15.8%
Market median
+6% vs market
20212024
Equity ratio
110.6%
This company
38.2%
Market median
+190% vs market
20212024
Return on equity
70.2%
This company
18.4%
Market median
+282% vs market
20212024
Net profit margin
12.9%
This company
8.1%
Market median
+59% vs market
20212024
Asset turnover
6.01×
This company
1.12×
Market median
+437% vs market
20212024
Debt / equity
-0.10×
This company
0.62×
Market median
+116% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-06-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
GD Chief Executive Officer | Chief Executive Officer | 2022 |
HH Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Neli Medicin AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gabriel Dasouki | Chief Executive Officer | 0 companies |
| Haidi Helén Dasouki | Deputy Chief Executive Officer | 0 companies |